Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

KPT-127 is toxic to hematological cancer cells

Jan. 4, 2011

Several inhibitors of botulinum neurotoxins presented at Pacifichem 2010

Jan. 4, 2011

MK-2461 is active in model of multiple myeloma

Jan. 3, 2011

IMMU-114 shows potential for treating GVHD

Jan. 3, 2011

Phase II data presented on AIC-246 for human cytomegalovirus infection

Jan. 3, 2011

Anti-HIV-1 activity of aciclovir and potentiation by ribavirin

Jan. 3, 2011

Selective SYK inhibitors P505-15 and P459-72 show anticancer potential

Jan. 3, 2011

HER2-Affitoxin is a potential therapeutic for HER2-overexpressing tumors

Dec. 31, 2010

CADA blocks HIV entry by disrupting translocation of CD4 across ER membrane

Dec. 31, 2010

Preclinical and clinical data presented on BEZ-235

Dec. 31, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...